Troy Income & Growth Trust
UK Equity Income
Rated fund 2013-19. A good option for relatively cautious investors
Despite a change to the management team in 2018, Troy Income & Growth remains a strong UK equity income offering. It is a particularly good option for relatively cautious investors, because it makes capital protection its main objective and offers a more defensive way to access the UK stockmarket.
Cantor Fitzgerald analyst Markuz Jaffe praises the trust’s relatively strong 2018. Most of its outperformance in the year came in the fourth quarter, when it shielded investors from losses incurred as ‘risk-off’ sentiment gripped markets.
Francis Brooke has run the trust since 2009. He was joined by co-manager Hugo Ure in 2015 and Mark Wharrier in October 2017. Wharrier’s stay was brief: he departed in May 2018. However, Morningstar believes the trust is sufficiently resourced given its structured, low turnover approach.
Brooke and Ure run a relatively concentrated portfolio of around 40 quality companies able to grow their dividends almost irrespective of what happens in the wider market. The trust yields 3.7% and pays dividends quarterly.
The managers have stuck to their approach through conditions favourable and unfavourable to their style.
They invest predominantly in UK companies but can also hold overseas shares. They buy companies they believe can generate growing amounts of cash well into the future. Businesses with high returns on invested capital that are sustained by durable competitive advantages are also targeted.
These firms are bought when three further conditions are met: they must have strong balance sheets, management teams that will act in the best interests of shareholders and share prices that underestimate future cash flows.
The trust has operated a discount control policy since 2010, so its shares tend to trade at close to the value of its assets.
Narrative and ratings content all as of 01 January 2019.See all Money Observer rated funds
|Unilever PLC||5.26 %|
|Royal Dutch Shell PLC B||4.48 %|
|Lloyds Banking Group PLC||4.38 %|
|GlaxoSmithKline PLC||4.27 %|
|BP PLC||4.03 %|
|Compass Group PLC||3.87 %|
|Experian PLC||3.49 %|
|RELX PLC||3.45 %|
|AstraZeneca PLC||3.28 %|
|Nestle SA||3.09 %|
|United Kingdom||81.12 %|
|United States||15.62 %|
|Consumer Defensive||23.98 %|
|Financial Services||19.94 %|
|Consumer Cyclical||11.55 %|
|Real Estate||7.63 %|
|Communication Services||5.94 %|
Hugo joined Troy in 2009 from Kleinwort Benson, where he was an equity analyst. Hugo gained his MA in Geology from Oxford University in 1999, following which he spent five years serving with the Scots Guards. He holds the CISI Diploma and is a CFA Charterholder.
Francis graduated from Edinburgh University in 1986, following which he worked at Kleinwort Benson Securities and Foreign & Colonial Management Ltd, where he was appointed Director in 1995. From 1997 to 2004 he worked for Merrill Lynch Investment Managers as a Director. He was also a member of both the Asset Allocation & Sector Strategy Committees at MLIM. In 2004 he left to join Troy.
Data provided by Morningstar.
The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.
This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.
You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.